![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090831
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203533
https://www.pharmacompass.com/pdf/news/aurobindos-generic-risedronate-sodium-received-approval-in-us-1477569051.pdf
http://www.pharmatimes.com/news/amgens_prolia_shows_promise_in_glucocorticoid_osteoporosis_1116045
https://www.pharmacompass.com/pdf/news/orchid-hlthcares-generic-risedronate-sodium-tentatively-approved-in-us-to-treat-osteoporosis-1454409953.pdf
https://www.pharmacompass.com/pdf/news/macleods-pharmas-generic-risedronate-sodium-approved-in-us-for-osteoporosis-1449826481.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-gets-usfda-nod-to-market-generic-osteoporosis-drug/articleshow/49996338.cms
http://www.streetinsider.com/Corporate+News/Teva+Pharma+(TEVA)+Announces+U.S.+Launch+of+Generic+Actonel+Tabs/10611009.html
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=111850&utm_source=twitter&utm_medium=twitterfeed&utm_campaign=pharminews#.VRp1MPyUdqV